Education
About Us
Working with TipRanks
Follow Us
Protagonist Therapeutics (DE:PGF)
BERLIN:PGF
PGF Analyst Ratings
Strong Buy
13 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
PGF Stock 12 Month Forecast
Average Price Target
€77.21
▲(12.72% Upside)
| Highest Price Target€97.17 | Average Price Target€77.21 | Lowest Price Target€62.46 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
BTIG
€71.14
Buy
3.85%
Upside
Reiterated
11/03/25
H.C. Wainwright
€69.4
Buy
1.32%
Upside
Reiterated
10/28/25
Truist Financial
€65.93→€76.34
Buy
11.45%
Upside
Reiterated
10/28/25
Wedbush
€60.73→€74.61
Buy
8.92%
Upside
Reiterated
10/28/25
Citi
€62.46→€83.28
Buy
21.58%
Upside
Reiterated
10/20/25
BMO Capital
€62.46→€97.17
Buy
41.85%
Upside
Reiterated
10/13/25
Clear Street
€53.79→€64.2
Buy
-6.28%
Downside
Reiterated
10/07/25
Barclays
€62.46
Buy
-8.81%
Downside
Initiated
09/16/25
Citizens JMP
€58.13→€59.86
Buy
-12.61%
Downside
Reiterated
08/07/25
TD Cowen
€56.39
Buy
-17.68%
Downside
Reiterated
08/06/25
J.P. Morgan
€57.26
Buy
-16.41%
Downside
Reiterated
07/01/25
Jefferies
€58.99
Buy
-13.88%
Downside
Reiterated
04/10/25
Goldman Sachs
€37.3→€32.97
Hold
-51.87%
Downside
Reiterated
02/24/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
BTIG
€71.14
Buy
3.85%
Upside
Reiterated
11/03/25
H.C. Wainwright
€69.4
Buy
1.32%
Upside
Reiterated
10/28/25
Truist Financial
€65.93→€76.34
Buy
11.45%
Upside
Reiterated
10/28/25
Wedbush
€60.73→€74.61
Buy
8.92%
Upside
Reiterated
10/28/25
Citi
€62.46→€83.28
Buy
21.58%
Upside
Reiterated
10/20/25
BMO Capital
€62.46→€97.17
Buy
41.85%
Upside
Reiterated
10/13/25
Clear Street
€53.79→€64.2
Buy
-6.28%
Downside
Reiterated
10/07/25
Barclays
€62.46
Buy
-8.81%
Downside
Initiated
09/16/25
Citizens JMP
€58.13→€59.86
Buy
-12.61%
Downside
Reiterated
08/07/25
TD Cowen
€56.39
Buy
-17.68%
Downside
Reiterated
08/06/25
J.P. Morgan
€57.26
Buy
-16.41%
Downside
Reiterated
07/01/25
Jefferies
€58.99
Buy
-13.88%
Downside
Reiterated
04/10/25
Goldman Sachs
€37.3→€32.97
Hold
-51.87%
Downside
Reiterated
02/24/25
Best Analysts Covering Protagonist Therapeutics
1 Month
xxx
Success Rate
15/22 ratings generated profit
Average Return
+10.96%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 68.18% of your transactions generating a profit, with an average return of +10.96% per trade.
3 Months
xxx
Success Rate
10/12 ratings generated profit
Average Return
+18.78%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 83.33% of your transactions generating a profit, with an average return of +18.78% per trade.
1 Year
Success Rate
22/22 ratings generated profit
Average Return
+85.12%
reiterated a buy rating 3 days ago
Copying Jonathan Wolleben's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +85.12% per trade.
2 Years
xxx
Success Rate
22/22 ratings generated profit
Average Return
+198.56%
reiterated a xxx
rating 3 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +198.56% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
PGF Analyst Recommendation Trends
Rating
Jul 25
Aug 25
Sep 25
Oct 25
Nov 25
Strong Buy
8
5
3
1
0
Buy
11
15
17
24
21
Hold
6
2
0
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
25
22
20
26
22
Each month's total comprises the sum of three months' worth of ratings.
PGF Financial Forecast
PGF Stock Forecast FAQ
What is DE:PGF’s average 12-month price target, according to analysts?
Based on analyst ratings, Protagonist Therapeutics’s 12-month average price target is 77.21.
What is DE:PGF’s upside potential, based on the analysts’ average price target?
Protagonist Therapeutics has 12.72% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Protagonist Therapeutics a Buy, Sell or Hold?
Protagonist Therapeutics has a consensus rating of Strong Buy, which is based on 13 buy ratings, 0 hold ratings and 0 sell ratings.
What is Protagonist Therapeutics’s share price target?
The average share price target for Protagonist Therapeutics is 77.21. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €97.17 ,and the lowest forecast is €62.46. The average share price target represents 12.72% Increase from the current price of €68.5.
The highest analyst share price target is €97.17 ,and the lowest forecast is €62.46. The average share price target represents 12.72% Increase from the current price of €68.5.
What do analysts say about Protagonist Therapeutics?
Protagonist Therapeutics’s analyst rating consensus is a Strong Buy. This is based on the ratings of 13 Wall Streets Analysts.
How can I buy shares of Protagonist Therapeutics?
To buy shares of DE:PGF, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.